Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance

American Journal of Physiology - Endocrinology and Metabolism

Volumn 282, Issue 2 45-2, 2002, Pages

  Sugita, Hiroki ^a   Kaneki, Masao ^a   Tokunaga, Eriko ^a   Sugita, Michiko ^a   Koike, Chieko ^b   Yasuhara, Shingo ^a   Tompkins, Ronald G ^a   Martyn, J A Jeevendra ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Aminoguanidine; Endotoxin; Euglycemic hyperinsulinemic clamp; Glycogen phosphorylase; Hepatic glucose output; Phosphoenolpyruvate carboxykinase

Indexed keywords

AMINOGUANIDINE; BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; GLYCOGEN PHOSPHORYLASE; INSULIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCONEOGENESIS; GLUCOSE INFUSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPSIS;

EID: 0036081598     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00087.2001     Document Type: Article

References (59)

1. Selective NOS inhibition restores myocardial contractility in endotoxemic rats; however, myocardial NO content does not correlate with myocardial dysfunction
2. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase
3. Modulation of basal hepatic glycogenolysis by nitric oxide
4. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme
5. Glycogen synthase and phosphorylase activities during glycogen repletion in endotoxemic rats
6. Nitric oxide and infectious diseases
7. Altered levels of mRNA encoding enzymes of hepatic glucose metabolism in septic rats
8. Muscle wasting associated with endotoxemia in the rat: Modification by the beta 2-adrenoceptor agonist clenbuterol
9. Effect of subcutaneous Escherichia coli-induced hypermetabolic sepsis on hepatic gluconeogenesis and its hormonal responsiveness in the rat
10. NOX a novel nitric oxide scavenger, reduces bacterial translocation in rats after endotoxin challenge
11. Regulation of glycogen synthesis in rat skeletal muscle after glycogen-depleting contractile activity: Effects of adrenaline on glycogen synthesis and activation of glycogen synthase and glycogen phosphorylase
12. Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide
13. Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase
14. Adrenergic blockade does not abolish elevated glucose turnover during bacterial infection
15. Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity
16. Functional role for protein kinase Cbeta as a regulator of stress-activated protein kinase activation and monocytic differentiation of myeloid leukemia cells
17. Expression of nitric oxide synthase in skeletal muscle: A novel role for nitric oxide as a modulator of insulin action
18. In vivo lipopolysaccharide pretreatment inhibits cGMP release from the isolated-perfused rat lung
19. Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta 12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression
20. Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism
21. Fever is not responsible for the elevated glucose kinetics in sepsis
22. Insulin-mediated glucose uptake by individual tissues during sepsis
23. Endotoxin-induced decrease in muscle protein synthesis is associated with changes in eIF2B, eIF4E, and IGF-I
24. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock
25. Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: Relationship to endogenous glucose production and peripheral tissue glucose uptake
26. Liver glycogen metabolism in endotoxin shock. II. Endotoxin administration increases glycogen phosphorylase activities in dog livers
27. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
28. Endotoxin and fibrinogen degradation product-D have different actions on carbohydrate metabolism: Role of Kupffer cells
29. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo
30. The hyperglycemic effect of S-nitrosoglutathione in the dog
31. Lack of effect of sodium nitroprusside on insulin-mediated blood flow and glucose disposal in the elderly
32. Bacterial translocation is inhibited in inducible nitric oxide synthase knockout mice after endotoxin challenge but not in a model of bacterial overgrowth
33. Expression of inducible nitric oxide synthase in human burn wounds
34. Characterization of the isolated rat flexor digitorum brevis for the study of skeletal muscle phosphorylase kinase phosphorylation
35. Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: A study with aminoguanidine in C57/BLKsJ diabetic mice
36. HIV-1-infection in the CNS. A pathogenesis of some neurological syndromes in the light of recent investigations
37. White adipose tissue nitric oxide synthase: A potential source for NO production
38. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene
39. Dose-dependent attenuation of lipopolysaccharide-fever by inhibitors of inducible nitric oxide-synthase in guinea pigs
40. Effect of increased cardiac output on liver blood flow, oxygen exchange and metabolic rate during longterm endotoxin-induced shock in pigs
41. Inhibition of nitric oxide synthesis in wounds: Pharmacology and effect on accumulation of collagen in wounds in mice
42. Role of nitric oxide in obesity-induced beta cell disease
43. Altered control of carbohydrate metabolism in endotoxemia
44. Nitric oxide inhibits glycogen synthesis in isolated rat hepatocytes
45. The stimulation of liver phosphorylase b by AMP, fluoride and sulfate. A technical note on the specific determination of the a and b forms of liver glycogen phosphorylase
46. Nitric oxide in the pathogenesis of sepsis
47. Prevention of glucose toxicity in HIT-T 15 cells and Zucker diabetic fatty rats by antioxidants
48. Deconstructing type 2 diabetes
49. Norepinephrine and Nω-monomethyl-L-arginine in porcine septic shock: Effects on hepatic O 2 exchange and energy balance
50. Increased production of nitrotyrosine in lung tissue of rats with radiation-induced acute lung injury
51. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice
52. On the mechanism of inactivation of muscle glycogen phosphorylase by insulin
53. Mechanisms of hepatic and peripheral insulin resistance during acute infections in humans
54. Incorporation of [3-3H]]glucose and 2-[1-14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: Implications for the quantitation of tissue glucose uptake
55. Role of prostaglandins in mediating alterations in glucose metabolism during acute endotoxemia in the rat
56. Differential effects of leptin in regulation of tissue glucose utilization in vivo
57. Congenital NOS2 deficiency protects mice from LPS-induced hyporesponsiveness to inhaled nitric oxide
58. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: Evidence for a late phase of nitric oxide-mediated reperfusion injury
59. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation